Followers

0
0
7
7
.
3
3
4
4
1
1
,
1
1
47.40 (4.32%)

As on 21 Oct, 2025 | 14:57

Open Trading A/c
Day Range
1,102.80
1,184.80
LH
52 Week Range
802.00
1,309.90
LH
Volume
* i
Bid / Ask
206,533.00
0.00 / 0.00

Jubilant Pharmova Announcements

Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider and...

14 Oct, 2025 | 07:10pm • Source: BSE

Jubilant Pharmova Limited has informed the Exchange about General Updates - Press Release pertaining to the launch of New High-Speed Isolator based Line, at its...

10 Oct, 2025 | 09:45am • Source: NSE

Intimation under Reg 30 - Launch of New High Speed Isolator base line at its Spokane Manufacturing Facility in US by Jubilant HollisterStier LLC

10 Oct, 2025 | 08:03am • Source: BSE

Submission of communication email sent to shareholders whose dividend(s) remains unpaid pursuant to "Saksham Niveshak - 100 Days Campaign"

08 Oct, 2025 | 08:20pm • Source: BSE

Compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

07 Oct, 2025 | 04:55pm • Source: BSE

Copy of Newspaper Publication

01 Oct, 2025 | 11:35pm • Source: BSE

Allotment of Optionally Convertible Redeemable Non-Cumulative Preference Shares(OCRPS) by Jubilant Biosys Limited, a wholly owned subsidiary Company

01 Oct, 2025 | 01:29pm • Source: BSE

Closure of Trading Window

30 Sep, 2025 | 06:35pm • Source: BSE

Appointment of CFO of the Company

23 Sep, 2025 | 11:40am • Source: BSE

Outcome of Board Meeting held on September 23, 2025

23 Sep, 2025 | 11:38am • Source: BSE

Disclosure under Regulation 30 - Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Obervations

20 Sep, 2025 | 08:35pm • Source: BSE

Reminder email sent to shareholders intimating about the 100 days campaign

12 Sep, 2025 | 08:02pm • Source: BSE

Disclosure under Regulation 30 - Receipt of Orders passed by the Additional Commissioner Central Tax (Appeals), Mysuru

02 Sep, 2025 | 11:42pm • Source: BSE

Disclosure under Regulation 30 - Completion of Sale and Transfer of API Business

01 Sep, 2025 | 11:42pm • Source: BSE

Jubilant Pharmova Limited has informed the Exchange about change in Management

01 Sep, 2025 | 02:41pm • Source: NSE

Resignation of Senior Management Personnel

01 Sep, 2025 | 01:54pm • Source: BSE

Resignation of Dr. Ramakrishnan Arul, Whole-Time Director of the Company

01 Sep, 2025 | 01:50pm • Source: BSE

Scrutinizer''s Report dated August 29, 2025.

29 Aug, 2025 | 09:46pm • Source: BSE

Proceedings and Voting results of 47th AGM.

29 Aug, 2025 | 09:43pm • Source: BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 18, 2025 for...

19 Aug, 2025 | 11:07am • Source: BSE